These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 18800883

  • 1. Inhaled sodium pyruvate improved FEV1 and decreased expired breath levels of nitric oxide in patients with chronic obstructive pulmonary disease.
    Votto JJ, Bowen JB, Barton RW, Thrall RS.
    J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):329-34. PubMed ID: 18800883
    [Abstract] [Full Text] [Related]

  • 2. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking.
    Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P.
    Respir Med; 1999 Jun; 93(6):389-96. PubMed ID: 10464820
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM, Rice KL, Janoff EN, Rector TS, Niewoehner DE.
    Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
    [Abstract] [Full Text] [Related]

  • 5. MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary disease.
    Bernstein JA, Liu N, Knorr BA, Smugar SS, Hanley WD, Reiss TF, Greenberg S.
    Respir Med; 2011 Mar; 105(3):392-401. PubMed ID: 20970976
    [Abstract] [Full Text] [Related]

  • 6. Bronchodilatory effects of NVA237, a once daily long-acting muscarinic antagonist, in COPD patients.
    Fogarty C, Hattersley H, Di Scala L, Drollmann A.
    Respir Med; 2011 Mar; 105(3):337-42. PubMed ID: 21144724
    [Abstract] [Full Text] [Related]

  • 7. A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison.
    Rennard S, Bantje T, Centanni S, Chanez P, Chuchalin A, D'Urzo A, Kornmann O, Perry S, Jack D, Owen R, Higgins M.
    Respir Med; 2008 Jul; 102(7):1033-44. PubMed ID: 18479895
    [Abstract] [Full Text] [Related]

  • 8. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease.
    John M, Bosse S, Oltmanns U, Schumacher A, Witt C.
    Respir Med; 2005 Nov; 99(11):1418-24. PubMed ID: 15894479
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM, Rajasekaran S, Paramesh P, Krishnarajasekar OR, Vasudevan S, Nalini K, Lakshmisubramanian S, Deivanayagam CN.
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [Abstract] [Full Text] [Related]

  • 11. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
    Brightling CE, McKenna S, Hargadon B, Birring S, Green R, Siva R, Berry M, Parker D, Monteiro W, Pavord ID, Bradding P.
    Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434
    [Abstract] [Full Text] [Related]

  • 12. Nitric oxide and exhaled breath nitrite/nitrates in chronic obstructive pulmonary disease patients.
    Liu J, Sandrini A, Thurston MC, Yates DH, Thomas PS.
    Respiration; 2007 Mar; 74(6):617-23. PubMed ID: 17643055
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term effects of budesonide on inflammatory status in COPD.
    Boorsma M, Lutter R, van de Pol MA, Out TA, Jansen HM, Jonkers RE.
    COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
    [Abstract] [Full Text] [Related]

  • 15. Alveolar-capillary membrane permeability for early prediction of response of inhaled steroid on patients with chronic obstructive pulmonary disease.
    Chou SH, Chen YW, Chuang HY, Kao EL, Huang MF.
    J Clin Pharm Ther; 2006 Aug; 31(4):363-8. PubMed ID: 16882106
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
    Jensen D, Amjadi K, Harris-McAllister V, Webb KA, O'Donnell DE.
    Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease.
    Kirkil G, Hamdi Muz M, Seçkin D, Sahin K, Küçük O.
    Respir Med; 2008 Jun; 102(6):840-4. PubMed ID: 18295467
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.
    van Noord JA, Cornelissen PJ, Aumann JL, Platz J, Mueller A, Fogarty C.
    Respir Med; 2009 Jan; 103(1):22-9. PubMed ID: 19022642
    [Abstract] [Full Text] [Related]

  • 20. The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients.
    Ozol D, Aysan T, Solak ZA, Mogulkoc N, Veral A, Sebik F.
    Respir Med; 2005 Dec; 99(12):1494-500. PubMed ID: 15946834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.